Skip to content

Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers

Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02989038
Acronym
NicRed
Enrollment
182
Registered
2016-12-12
Start date
2017-01-31
Completion date
2019-12-17
Last updated
2020-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence

Keywords

smoker, young adult, adolescent

Brief summary

The purpose of this study is to evaluate reactions to, and choices to self-administer, cigarette smoke with varying nicotine content among low-frequency, non-dependent adolescent/young adult smokers between the ages of 15-25 years.

Detailed description

Participants will undergo three sessions in which their reactions to fixed doses of smoke from investigational cigarettes with three different nicotine contents (15.8 mg/gram of tobacco, 2.5 mg/g, and .4 mg/g) will be assessed. Following the third fixed-dose session, participants will return to the lab to choose one of the cigarettes to self-administer.

Interventions

cigarettes with 0.03 nicotine yield with 0.4 mg/g nicotine content and 9.0 mg tar yield

OTHERIntermediate Nicotine Content Cigarettes

cigarettes with 0.12 nicotine yield with 2.4 mg/g nicotine content and 9.0 mg tar yield

cigarettes with 0.8 nicotine yield with 15.8 mg/g nicotine content and 10.5 mg tar yield

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
15 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* generally healthy * between the ages of 15-25 * use nicotine or tobacco products between 1-15 days/month for at least 6 months * smokes at least 5 cigarettes/month * no unstable or significant medical or psychiatric conditions * breath alcohol value=0.000 * able to provide contact information for two individuals who can corroborate smoking status

Exclusion criteria

* use of illegal drugs as measured by urine drug screen (excluding THC) * serious quit attempt in the past 3 months * plans to quit smoking in the next 2 months * current use of nicotine replacement therapy or other tobacco cessation products * inability to attend all required experimental sessions * blood pressure \>160/100 mmHg * pregnant, trying to become pregnant, or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Subjective reactions to fixed doses of tobacco smokeImmediately after puff administration of each study cigaretteSmoking Effects Questionnaire ratings following administration of puffs for NNC, INC, and VLNC cigarettes
Cigarette choice30 minutes after sampling all 3 study cigarettesParticipants will choose which of the three cigarettes they prefer to smoke by ranking each of the three cigarette conditions using a 1-3 scale where 1 is the cigarette that they most desire to smoke and 3 is the cigarette that they least desire to smoke.

Secondary

MeasureTime frameDescription
Mood and AffectImmediately after puff administration of each study cigaretteThe Positive and Negative Affect Schedule (PANAS)
Smoking topography - Change in Carbon Monoxide (CO) values (in parts per million, ppm) following puff administrationImmediately after puff administration of each study cigaretteCO values (in ppm) will be obtained using a handheld CO monitor prior to puff administration and 5 minutes after completion of cigarette puff administration. The difference in values will provide a CO boost value
Smoking topography - number of puffsDuring self-administration of chosen cigarette at the last experimental session (approximately over 10 minutes)number of puffs
Smoking topography - interpuff intervalDuring self-administration of chosen cigarette at the last experimental session (approximately over 10 minutes)Interpuff interval (in seconds) will be calculated using video recordings of self-administration of chosen cigarette

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026